MIG
VRTX icon

McGuire Investment Group’s Vertex Pharmaceuticals VRTX Stock Holding History

McGuire Investment Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03M Sell
4,084
-55
-1% -$24.4K 0.18% 70
2026
Q1 		$1.85M Sell
4,139
-314
-7% -$146K 0.21% 64
2025
Q4 		$2.02M Hold
4,453
– – 0.22% 62
2025
Q3 		$1.74M Sell
4,453
-661
-13% -$276K 0.2% 66
2025
Q2 		$2.28M Sell
5,114
-717
-12% -$330K 0.29% 58
2025
Q1 		$2.83M Sell
5,831
-178
-3% -$82.9K 0.42% 51
2024
Q4 		$2.42M Sell
6,009
-10
-0.2% -$4.63K 0.35% 53
2024
Q3 		$2.8M Hold
6,019
– – 0.39% 53
2024
Q2 		$2.82M Sell
6,019
-1
-0% -$434 0.4% 54
2024
Q1 		$2.52M Hold
6,020
– – 0.37% 56
2023
Q4 		$2.45M Hold
6,020
– – 0.41% 53
2023
Q3 		$2.09M Sell
6,020
-288
-5% -$101K 0.4% 52
2023
Q2 		$2.22M Hold
6,308
– – 0.41% 52
2023
Q1 		$1.99M Sell
6,308
-156
-2% -$46.8K 0.4% 50
2022
Q4 		$1.87M Hold
6,464
– – 0.4% 51
2022
Q3 		$1.87M Sell
6,464
-3
-0% -$863 0.43% 51
2022
Q2 		$1.82M Sell
6,467
-321
-5% -$85.9K 0.39% 53
2022
Q1 		$1.77M Hold
6,788
– – 0.32% 50
2021
Q4 		$1.49M Sell
6,788
-218
-3% -$42.4K 0.25% 55
2021
Q3 		$1.27M Sell
7,006
-118
-2% -$23K 0.24% 53
2021
Q2 		$1.44M Sell
7,124
-110
-2% -$23K 0.27% 51
2021
Q1 		$1.55M Sell
7,234
-4
-0.1% -$879 0.33% 46
2020
Q4 		$1.71M Buy
7,238
+107
+2% +$24.6K 0.42% 41
2020
Q3 		$1.94M Sell
7,131
-150
-2% -$41.4K 0.58% 41
2020
Q2 		$2.11M Sell
7,281
-175
-2% -$47.4K 0.73% 38
2020
Q1 		$1.77M Sell
7,456
-49
-0.7% -$11.2K 0.74% 38
2019
Q4 		$1.64M Sell
7,505
-76
-1% -$15.4K 0.49% 46
2019
Q3 		$1.28M Sell
7,581
-182
-2% -$32.2K 0.42% 48
2019
Q2 		$1.42M Sell
7,763
-225
-3% -$39.3K 0.45% 52
2019
Q1 		$1.47M Sell
7,988
-116
-1% -$21.4K 0.48% 50
2018
Q4 		$1.34M Buy
8,104
+10
+0.1% +$1.73K 0.51% 50
2018
Q3 		$1.56M Buy
+8,094
New +$1.44M 0.52% 49

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

McGuire Investment Group's VRTX Position: Q2 2026 in Review

McGuire Investment Group reduced its Vertex Pharmaceuticals (VRTX) stake by 1.3% in Q2 2026, selling an estimated $24.4K and leaving 4,084 shares worth $2.03M. The position accounts for 0.18% of the portfolio, ranked #70.

McGuire Investment Group first reported a position in VRTX in Q3 2018 and has held it in 32 quarters since. The position peaked at $2.83M in Q1 2025. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • McGuire Investment Group held 4,084 shares of Vertex Pharmaceuticals worth $2.03M as of Q2 2026.
  • McGuire Investment Group sold 55 Vertex Pharmaceuticals shares in Q2 2026, an estimated $24.4K.
  • Vertex Pharmaceuticals made up 0.18% of McGuire Investment Group's portfolio in Q2 2026, its #70 holding.
  • McGuire Investment Group first reported a position in Vertex Pharmaceuticals in Q3 2018 and has held it in 32 quarters since.
  • McGuire Investment Group's Vertex Pharmaceuticals position peaked at $2.83M in Q1 2025.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on McGuire Investment Group's 13F filing for Q2 2026, filed 27 Jul 2026.